 trial prophylactic ganciclovir cytomegalovirus pulmonary infection recipients allogeneic bone marrow transplants City Hope-Stanford-Syntex CMV Study Group BACKGROUND Cytomegalovirus CMV interstitial pneumonia major cause death allogeneic bone marrow transplantation controlled trial ganciclovir recipients bone marrow transplants asymptomatic pulmonary CMV infection risk factors development CMV interstitial pneumonia METHODS bone marrow transplantation patients evidence respiratory disease underwent routine bronchoalveolar lavage day patients positive cultures CMV prophylactic ganciclovir observation Ganciclovir mg kilogram body weeks times week day RESULTS culture-positive patients prophylactic ganciclovir percent CMV pneumonia day culture-positive control patients percent relative risk patient full course ganciclovir prophylaxis CMV interstitial pneumonia patients ganciclovir maximal serum creatinine levels equal mumol liter mg deciliter none controls CMV-negative patients percent CMV pneumonia rate untreated CMV-positive control patients relative risk predictors CMV pneumonia lavage-fluid culture positive CMV CMV-positive blood culture specimens day CONCLUSION recipients allogeneic bone marrow asymptomatic CMV infection lung major risk factor subsequent CMV interstitial pneumonia Prophylactic ganciclovir effective development CMV interstitial pneumonia patients asymptomatic infection